| Genetic diversity underlying the envelope glycoproteins of hepatitis C virus: structural and functional consequences and the implications for vaccine design AW Tarr, T Khera, K Hueging, J Sheldon, E Steinmann, T Pietschmann, ... Viruses 7 (7), 3995-4046, 2015 | 56 | 2015 |
| Hepatitis E virus replication and interferon responses in human placental cells L Knegendorf, SA Drave, VL Dao Thi, Y Debing, RJP Brown, ... Hepatology Communications 2 (2), 173-187, 2018 | 53 | 2018 |
| Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice RJP Brown, B Tegtmeyer, J Sheldon, T Khera, Anggakusuma, D Todt, ... Science advances 6 (45), eabd3233, 2020 | 37 | 2020 |
| Yellow fever: Integrating current knowledge with technological innovations to identify strategies for controlling a re-emerging virus RDV Kleinert, E Montoya-Diaz, T Khera, K Welsch, B Tegtmeyer, S Hoehl, ... Viruses 11 (10), 960, 2019 | 34 | 2019 |
| Reversal of immunity after clearance of chronic HCV infection—all reset? H Wedemeyer, T Khera, B Strunz, NK Björkström Frontiers in immunology 11, 571166, 2020 | 31 | 2020 |
| Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies D Bankwitz, A Bahai, M Labuhn, M Doepke, C Ginkel, T Khera, D Todt, ... Gut 70 (9), 1734-1745, 2021 | 25 | 2021 |
| Long-lasting imprint in the soluble inflammatory milieu despite early treatment of acute symptomatic hepatitis C T Khera, Y Du, D Todt, K Deterding, B Strunz, S Hardtke, A Aregay, K Port, ... The Journal of infectious diseases 226 (3), 441-452, 2022 | 23 | 2022 |
| Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants T Khera, P Behrendt, D Bankwitz, RJP Brown, D Todt, M Doepke, ... Journal of hepatology 70 (4), 593-602, 2019 | 22 | 2019 |
| Autoimmune hepatitis induction can occur in the liver J Dywicki, LE Buitrago‐Molina, J Pietrek, M Lieber, R Broering, T Khera, ... Liver international 40 (2), 377-381, 2020 | 13 | 2020 |
| Imprint of unconventional T‐cell response in acute hepatitis C persists despite successful early antiviral treatment Y Du, T Khera, B Strunz, K Deterding, D Todt, N Woller, SA Engelskircher, ... European Journal of Immunology 52 (3), 472-483, 2022 | 9 | 2022 |
| Distinct Immune Imprints of Post–Liver Transplantation Hepatitis C Persist Despite Viral Clearance A Aregay, B Engel, K Port, FWR Vondran, B Bremer, C Niehaus, T Khera, ... Liver Transplantation 27 (6), 887-899, 2021 | 6 | 2021 |
| Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy T Khera, D Todt, K Vercauteren, CP McClure, L Verhoye, A Farhoudi, ... Antiviral research 139, 129-137, 2017 | 6 | 2017 |
| The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection Y Du, OE Anastasiou, B Strunz, J Scheuten, B Bremer, A Kraft, ... Liver International 41 (9), 2046-2058, 2021 | 5 | 2021 |
| Natural killer cells regulate the maturation of liver sinusoidal endothelial cells thereby promoting intrahepatic T‐cell responses in a mouse model Y Du, H Yan, S Zou, T Khera, J Li, M Han, X Yang, B Wang, J Liu, S Sun, ... Hepatology Communications 5 (5), 865-881, 2021 | 5 | 2021 |
| Soluble inflammatory mediators identify HCV patients who may be cured with four weeks of antiviral treatment T Khera, LW Madsen, Y Du, ST Lillevang, PB Christensen, H Wedemeyer Journal of Viral Hepatitis 29 (6), 447-454, 2022 | 4 | 2022 |
| Controlled Attenuation Parameter Is Associated with a Distinct Systemic Inflammatory Milieu after Clearance of HCV Infection Y Du, T Khera, Z Liu, M Tudrujek-Zdunek, A Dworzanska, M Cornberg, ... Biomedicines 11 (6), 1529, 2023 | 2 | 2023 |
| Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies K Nagarathinam, A Scheck, M Labuhn, LJ Ströh, E Herold, B Veselkova, ... Science Advances 10 (49), eado2600, 2024 | | 2024 |
| Soluble inflammatory molecules do not completely normalize despite early treatment of acute symptomatic hepatitis C T Khera, Y Du, J Hengst, K Deterding, S Hardtke, B Strunz, N Bjorkstrom, ... Zeitschrift für Gastroenterologie 58 (01), 5.28, 2020 | | 2020 |
| NK cells regulate LSEC to promote the HBV-specific T cells response Y Du, S Zou, T Khera, EL Salomon, M Han, J Li, U Dittmer, M Lu, D Yang, ... Zeitschrift für Gastroenterologie 58 (01), 5.2, 2020 | | 2020 |
| DIFFERENTIAL IMPACT OF CIRRHOSIS AND TREATMENT REGIMEN ON SOLUBLE INFLAMMATORY MOLECULES IN CHRONIC HEPATITIS C K Tomasiewicz, T Khera, Y Du, M Tudrujek-Zdunek, A Dworzanska, ... HEPATOLOGY 70, 1009A-1010A, 2019 | | 2019 |
